Comparison of Gene-Editing Approaches for Severe Congenital Neutropenia-Causing Mutations in the ELANE Gene
The CRISPR Journal · 2024
DOI: 10.1089/crispr.2024.0006 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The CRISPR Journal, 2024. Verfasst von Malte Ulrich Ritter und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Oncology, Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Gene Editing, Neutropenia, Congenital Bone Marrow Failure Syndromes, CRISPR-Cas Systems. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Safety considerations for gene therapies of inherited preleukemia syndromes, including severe congenital neutropenia (CN), are paramount. We compared several strategies for CRISPR/Cas9 gene editing of autosomal-dominant ELANE mutations in CD34 + cells from two CN patients head-to-head. We tested universal and allele-specific ELANE knockout, ELANE mutation correction by homology-directed repair (HDR) with AAV6, and allele-specific HDR with ssODN. All strategies were not toxic, had at least 30% editing, and rescued granulopoiesis in vitro . In contrast to published data, allele-specific indels in the last exon of ELANE also restored granulopoiesis. Moreover, by implementing patient-derived induced pluripotent stem cells for GUIDE-Seq off-target analysis, we established a clinically relevant “personalized” assessment of off-target activity of gene editing on the background of the patient’s genome. We found that allele-specific approaches had the most favorable off-target profiles. Taken together, a well-defined head-to-head comparison pipeline for selecting the appropriate gene therapy is essential for diseases with several gene editing strategies available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Oncology, Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
- Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation, University Hospital Tübingen, Tübingen, Germany.
- Gene and RNA Therapy Center, Tübingen University, Tübingen, Germany.
ORCID-Profile: Julia Skokowa
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Ritter, M. U., Nasri, M., Dannenmann, B., Mir, P., Secker, B., Amend, D., Klimiankou, M., Welte, K., & Skokowa, J. (2024). Comparison of Gene-Editing Approaches for Severe Congenital Neutropenia-Causing Mutations in the ELANE Gene. The CRISPR Journal. https://doi.org/10.1089/crispr.2024.0006
Vancouver
Ritter MU, Nasri M, Dannenmann B, Mir P, Secker B, Amend D, et al. Comparison of Gene-Editing Approaches for Severe Congenital Neutropenia-Causing Mutations in the ELANE Gene. The CRISPR Journal. 2024. doi:10.1089/crispr.2024.0006
BibTeX
@article{Ritter2024,
author = {Ritter, Malte Ulrich and Nasri, Masoud and Dannenmann, Benjamin and Mir, Perihan and Secker, Benjamin and Amend, Diana and Klimiankou, Maksim and Welte, Karl and Skokowa, Julia},
title = {Comparison of Gene-Editing Approaches for Severe Congenital Neutropenia-Causing Mutations in the ELANE Gene},
journal = {The CRISPR Journal},
year = {2024},
doi = {10.1089/crispr.2024.0006}
}
EUVIMED